LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Author:
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference39 articles.
1. Humanization of an anti-p185HER2 antibody for human cancer therapy.
2. Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
3. Basal-like breast carcinomas: clinical outcome and response to chemotherapy
4. MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
5. The Wnt signaling pathway and its role in tumor development
Cited by 168 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNAs as the critical regulators of tumor angiogenesis in liver cancer;Pathology - Research and Practice;2023-11
2. Wnt1 induces osteoblastic changes in a well‐established osteolytic skeletal metastatic model derived from breast cancer;Cancer Reports;2023-10-15
3. Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC);Molecular and Cellular Biochemistry;2023-05-29
4. The role of the NDRG1 in the pathogenesis and treatment of breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05
5. Screening and Identification of ssDNA Aptamers for Low-Density Lipoprotein (LDL) Receptor-Related Protein 6;Molecules;2023-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3